Published in


Scientists Dodge FDA to Offer a $1 Million Anti-Aging Treatment in Colombia

The unproven gene therapy aims to lengthen a person’s telomeres

An elderly woman’s hands with IVs and hospital bracelets.
Photo: cstar55/E+/Getty Images

Would you pay $1 million and fly to South America for a chance to live longer?

Libella Gene Therapeutics, a Kansas-based company that says it is developing a gene therapy that can reverse aging by up to 20…




The undercurrents of the future. A publication from Medium about technology and people.

Recommended from Medium

Prime Editing — The Word Processor of Genetics

GN/ CROPSR: A new tool to accelerate genetic discoveries

GN/ Dynamics of DNA replication ‘licensing’ revealed

Whole Genome Sequencing (WGS) and Chronic Inflammatory Diseases: A Potential Area of Opportunity?

Getting Cultured: The Perfect Marriage Between Technology and Biology

Let’s Talk: The Ethical AI Conversation, and How Biotech Is Failing

An Inside Look at Variant Bio: The Standley Fellowship Experience

Ancestry DNA Testing Websites Are the Feds

Get the Medium app

A button that says 'Download on the App Store', and if clicked it will lead you to the iOS App store
A button that says 'Get it on, Google Play', and if clicked it will lead you to the Google Play store
Emily Mullin

Emily Mullin

Former staff writer at Medium, where I covered biotech, genetics, and Covid-19 for OneZero, Future Human, Elemental, and the Coronavirus Blog.

More from Medium

Why You Should Spend Time Walking Barefoot Every Day

Why we should implement microdosing in our social rituals

Kratom, the Latest in a Long Line of Controversial Supplements

Micro-Dosing: My Personal Experience on Mushrooms (& How I Feel About Them Now)